Dermira to Present Data for DRM01 Acne Program at 45th Annual ESDR Meeting
03 sept. 2015 07h30 HE
|
Dermira, Inc.
MENLO PARK, Calif., Sept. 3, 2015 (GLOBE NEWSWIRE) -- Dermira, Inc. (NASDAQ:DERM), a specialty biopharmaceutical company focused on bringing innovative and differentiated products to dermatologists...
Dermira Reports Second Quarter 2015 Financial Results and Provides Corporate Update
13 août 2015 16h15 HE
|
Dermira, Inc.
Two Product Candidates Now in Phase 3 Development
Approximately $104 Million in Net Proceeds From Recent Follow-on Public Offering
MENLO PARK, Calif., Aug. 13, 2015 (GLOBE NEWSWIRE) -- Dermira,...
Dermira Announces Closing of Follow-on Public Offering of Common Stock and Full Exercise of Underwriters' Option to Purchase Additional Shares
11 août 2015 16h05 HE
|
Dermira, Inc.
MENLO PARK, Calif., Aug. 11, 2015 (GLOBE NEWSWIRE) -- Dermira, Inc. (NASDAQ:DERM), a specialty biopharmaceutical company focused on bringing innovative and differentiated products to dermatologists...
Dermira Prices Follow-On Public Offering of Common Stock
05 août 2015 20h29 HE
|
Dermira, Inc.
MENLO PARK, Calif., Aug. 5, 2015 (GLOBE NEWSWIRE) -- Dermira, Inc. (NASDAQ:DERM), a specialty biopharmaceutical company focused on bringing innovative and differentiated products to dermatologists and...
Dermira Commences Follow-on Public Offering of Common Stock
04 août 2015 16h01 HE
|
Dermira, Inc.
MENLO PARK, Calif., Aug. 4, 2015 (GLOBE NEWSWIRE) -- Dermira, Inc. (NASDAQ:DERM), a specialty biopharmaceutical company focused on bringing innovative and differentiated products to dermatologists and...
Dermira Doses First Patients in DRM04 Phase 3 Program in Axillary Hyperhidrosis
03 août 2015 07h30 HE
|
Dermira, Inc.
Two Identical Studies to Enroll a Combined Total of 660 Patients
Topline Phase 3 Data Expected in the Second Half of 2016
Represents Dermira's Second Product Candidate in Phase 3...
Dermira's Phase 2a DRM01 Acne Trial Data Presented at the World Congress of Dermatology Meeting
09 juin 2015 07h30 HE
|
Dermira, Inc.
MENLO PARK, Calif., June 9, 2015 (GLOBE NEWSWIRE) -- Dermira, Inc. (Nasdaq:DERM), a specialty biopharmaceutical company focused on bringing innovative and differentiated products to dermatologists and...
Dermira Announces Poster Presentation on DRM01 in Acne at World Congress of Dermatology
02 juin 2015 07h30 HE
|
Dermira, Inc.
MENLO PARK, Calif., June 2, 2015 (GLOBE NEWSWIRE) -- Dermira, Inc. (Nasdaq:DERM), a specialty biopharmaceutical company focused on bringing innovative and differentiated products to dermatologists and...
Dermira to Present at Jefferies 2015 Global Healthcare Conference
28 mai 2015 07h30 HE
|
Dermira, Inc.
MENLO PARK, Calif., May 28, 2015 (GLOBE NEWSWIRE) -- Dermira, Inc. (Nasdaq:DERM), a specialty biopharmaceutical company focused on bringing innovative and differentiated products to dermatologists and...
Dermira Reports First Quarter 2015 Financial Results and Provides Corporate Update
12 mai 2015 16h13 HE
|
Dermira, Inc.
MENLO PARK, Calif., May 12, 2015 (GLOBE NEWSWIRE) -- Dermira, Inc. (Nasdaq:DERM), a specialty biopharmaceutical company focused on bringing innovative and differentiated products to dermatologists and...